Literature DB >> 18762780

Aggressive combined-modality therapy for squamous cell carcinoma of the female urethra.

Steve Nicholson1, David Tsang, Duncan Summerton.   

Abstract

BACKGROUND: A 48-year old woman presented to an emergency department with acute urinary retention necessitating suprapubic catheterization. INVESTIGATIONS: Pelvic examination under anesthetic by both a urologist and gynecologist, biopsy of the urethral tumor and of the cervix, pathological analysis, MRI of the pelvis, CT of the chest, abdomen and pelvis. DIAGNOSIS: Poorly differentiated squamous cell carcinoma of the urethra, T4N0M0. MANAGEMENT: The patient received two cycles of neoadjuvant TIP (paclitaxel, ifosfamide, cisplatin) chemotherapy, resulting in complete remission, followed by consolidative chemoradiation therapy (radiation therapy given with synchronous weekly cisplatin). She remained relapse-free 48 months after diagnosis, with normal voiding and sexual function.

Entities:  

Mesh:

Year:  2008        PMID: 18762780     DOI: 10.1038/ncpuro1211

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  3 in total

1.  Successful management of female urethral carcinoma with radiation therapy and concurrent chemotherapy.

Authors:  William J Magnuson; Kristin Bradley; Mark Shaves
Journal:  Gynecol Oncol Case Rep       Date:  2011-11-04

2.  Non-surgical treatment of primary female urethral cancer.

Authors:  Bruce Libby; David Chao; Bernard F Schneider
Journal:  Rare Tumors       Date:  2010-09-30

Review 3.  A Rare Case of Advanced Urethral Diverticular Adenocarcinoma and a Review of Treatment Modalities.

Authors:  Fatai Oluyadi; Preethi Ramachandran; Vladmir Gotlieb
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.